论文部分内容阅读
慢性肺心病急性期常易开发上消化道出皿,严重者可导致失血性休克,成为病人的直接死亡原因.近年来,我们应用H_2受体阻滞剂预防该病疗效显著,现报告如下:1 资料与方法1.1 一般资料 48例慢性肺心病住院病人,分为二组:治疗组24例,男18例,女6例,平均年龄61.6岁±7.6岁(52岁～74岁),对照组24例,男19例,女5例,平均年龄61.8岁±7.5岁(53岁～72岁).48例均符合1980年全国第三次肺心病专业会议修订的诊断标准.均系 Ⅱ型呼吸衰竭,心衰程度≥Ⅱ°.二组患者在性别、年龄、病程、呼吸衰竭及心力衰竭
Chronic pulmonary heart disease in the acute stage often easy to develop upper gastrointestinal plate, severe cases can lead to hemorrhagic shock, a direct cause of death in patients in recent years, we use H_2 receptor blocker to prevent the disease a significant effect, are as follows: 1 Materials and Methods 1.1 General Information 48 cases of chronic pulmonary heart disease inpatients, divided into two groups: the treatment group of 24 patients, 18 males and 6 females, mean age 61.6 years ± 7.6 years (52 years to 74 years), the control group 24 cases, 19 males and 5 females, with an average age of 61.8 years ± 7.5 years (53 years to 72 years) .48 cases were all in line with the revised diagnostic criteria of the third national conference of pulmonary heart disease in 1980. All were type Ⅱ respiration Failure, heart failure degree Ⅱ ° .The two groups of patients in gender, age, duration, respiratory failure and heart failure